UK MHRA approves Vertex’s Alyftrek, a once-daily next-in-class CFTR modulator to treat cystic fibrosis: London Monday, March 10, 2025, 10:00 Hrs [IST] Vertex Pharmaceuticals, a ...
There are hundreds of publicly traded companies on various equity markets worldwide. Investors choose to put their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback